Statins Could Increase Type 2 Diabetes Risk
A new study done in Finland has suggested that patients who take statin drugs, which are typically prescribed for lowering cholesterol levels could in fact be increasing their Type 2 diabetes risk. The researchers found that the use of statins increased the risk of developing Type 2 diabetes by almost 50 percent.
Statins are connected to Type 2 diabetes risks in several ways. First, the drug can cause a person to become insulin resistant and the other way in which statins cause diabetes is that they impair the function of the pancreas in secreting insulin.
The researchers also said that the study was done only on white men so additional studies would need to be performed in order to find out the risk to women or other racial groups. There are over 29 million people in the United States that have diabetes. Type 2 diabetes typically results when the body becomes insulin resistant. As compensation, the body increases the amount of insulin that it produces. Having excess weight and a lifestyle that lacks sufficient exercise are two risk factors that significantly increase the likelihood that diabetes will develop.
This study, performed at the University of Eastern Finland looked at statin treatment in roughly 9,000 men that didn’t have diabetes. As the study progressed over time, roughly 625 men had developed Type 2 diabetes. The drugs that were found to increase the risk were simvastatin (Zocor) and atorvastatin (Lipitor).